Rat Models of Ischemic Optic Neuropathy in the MICRON Literature

About the MICRON Research Literature

These research pages organize published studies using MICRON imaging systems by animal species and the disease or condition investigated.

All publication counts and figures reflect the complete indexed research collection.

Explore related studies through the MICRON Research Hubs or search the complete publication collection in the reSEARCH portal.

Understanding Ischemic Optic Neuropathy

Ischemic optic neuropathy is infarction of the optic nerve, and the axons that die are those of retinal ganglion cells passing through it, so the damage is read downstream as ganglion cell loss while its cause sits in the nerve's own blood supply.

In the anterior form the infarct is at the nerve head, which draws its blood from the posterior ciliary circulation rather than from the retinal vessels and swells visibly when that supply fails. A posterior form, infarcting the retrobulbar nerve without visible swelling of the disc, is also described.

The non-arteritic presentation in people is sudden painless loss of vision in one eye, often noticed on waking, with disc swelling that gives way over weeks to pallor and often an altitudinal or arcuate field defect, frequently respecting the horizontal meridian. It is described as arising in a structurally predisposed eye: a small disc with a small or absent physiological cup, graded clinically against the range of cup sizes human eyes show and named a disc at risk.

The arteritic presentation is a different problem in the same place, an ocular manifestation of giant cell arteritis, a systemic vasculitis that threatens the fellow eye within days to weeks and is handled as an emergency in its own right.

Ischemic Optic Neuropathy in Experimental Research

What a rodent model supplies is an infarct placed in time: one established route induces it photochemically, with a photosensitizing dye such as rose bengal given systemically and then activated by light directed at the nerve head to thrombose the small vessels feeding it, and another delivers a vasoconstrictor at the nerve.

Placing the infarct in time means that:

• Onset, side and severity are set rather than inferred from when a patient noticed a change
• The fellow eye is available as a control wherever the measure in question is not itself altered by injury to the other side
• The nerve and its ganglion cells can be imaged, measured functionally and examined histologically at chosen times after a dated insult, including under a treatment given on a known schedule

What such a model does not supply is the predisposition: a rat optic nerve head carries no cup-to-disc configuration comparable to the one graded in human eyes, and it is supported by a glial rather than a collagenous lamina, so what is reproduced is the infarction and not the structural vulnerability that distinguishes one person's nerve from another's. The arteritic route, whose lesion is an inflamed systemic artery rather than a thrombosed small vessel, and the endpoints by which the human disease is followed, a reported acuity and a mapped visual field, sit outside it as well.

Rat Models of Ischemic Optic Neuropathy

The rat offers a larger eye than the mouse while remaining a small-animal model, which eases injection and imaging without moving to a large species.

Published MICRON Research: Ischemic Optic Neuropathy in Rats

This page lists 5 papers from the MICRON literature, published 2017 to 2022, that study ischemic optic neuropathy in rats.

Of these publications:

• 5 studies used rats as the primary ischemic optic neuropathy disease model.

Scope of the literature collection: Publication counts reflect studies identified and indexed in the MICRON research corpus. This collection is not intended to represent an exhaustive review of all published ischemic optic neuropathy research.

Which imaging and experimental techniques are used in these studies?

Technique counts are paper-level co-occurrences and do not necessarily indicate that a technique was applied to the focal species or focal disease model.

Capabilities and Limitations of Imaging Techniques

A summary of what each imaging technique listed above can measure, the information it provides, and its limitations in research applications.

Intravitreal Injection / Delivery

Injection into the vitreous places a substance directly into the vitreous at a known administered dose and chosen time, reducing but not eliminating systemic exposure. The injectate may be a therapeutic compound, cell preparation or viral vector, or an agent used to create the model, such as a toxin, vasoactive or excitotoxic compound, or infectious inoculum. The route bypasses surface-delivery barriers and provides direct access to the vitreous and posterior segment, but the concentration reached in a particular ocular tissue depends on distribution and clearance and is not fixed by the injected dose alone. It is invasive and discrete: each repeat dose or challenge requires another injection, and vehicle- or sham-injected controls can help separate effects of the injectate from effects of the procedure.

Optical Coherence Tomography

Optical coherence tomography provides high-resolution, cross-sectional images of ocular tissues in the living eye, allowing researchers to visualize structures at different depths. OCT is particularly useful for measuring tissue thickness, identifying structural abnormalities, and assessing the location and extent of tissue changes.

As a non-invasive imaging technique, OCT enables repeated measurements in the same eye over time, supporting longitudinal studies of disease progression and treatment response. Although OCT provides detailed structural information, it does not directly measure cellular activity or visual function. Tissue that appears structurally normal may still have functional abnormalities, making OCT a valuable companion to functional assessments such as electroretinography (ERG).

Topical Ophthalmic Drug Delivery

A compound applied as drops to the ocular surface. It is non-invasive and repeatable, so it supports frequent dosing without a procedure for each dose. What the route has to establish depends on the target: for an ocular-surface target, residence time and penetration into the surface tissue are the main barriers; for an intraocular anterior-segment target, the compound must cross ocular-surface and corneal or conjunctival barriers and reach an intraocular concentration sufficient for the experiment; for a posterior-segment target, additional ocular barriers separate the surface from the target and posterior-segment exposure is harder to establish.

Electroretinography

Records the retina's electrical response to light, giving component-sensitive information about outer- and inner-retinal function. It measures function directly, which no structural method does. Full-field ERG sums across the whole retina, so a small lesion can leave the trace unchanged; focal and multifocal variants trade signal amplitude for spatial resolution.

Which MICRON systems and add-ons appear?

Which strains and genetic lines are used?

What other conditions are recorded on the same papers?

Which MICRON configurations appear in this work?

Configurations recorded in these papers, and the techniques recorded alongside them.

The papers

Browse all hubs at MICRON Research Hubs. The full corpus is searchable in the reSEARCH portal.